B Conrad - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B Conrad

Showing results (281-290 of 283) with videos related to

Pageof 29

Sort By:

You have reached the last page of results.This site can display upto 283 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.

Physical Review Letters|August 26, 2022

Lawson Criterion for Ignition Exceeded in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.

Physical Review Letters|February 23, 2024

Achievement of Target Gain Larger than Unity in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.

Pageof 29

Search research articles

Showing results (281-290 of 283) with videos related to

Sort By:

Pageof 29

You have reached the last page of results.This site can display upto 283 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.

Physical Review Letters|August 26, 2022

Lawson Criterion for Ignition Exceeded in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.

Physical Review Letters|February 23, 2024

Achievement of Target Gain Larger than Unity in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.

Pageof 29